Biology Reference
In-Depth Information
28. Emini EA, Ellis RW, Miller WJ,
et al
. (1986) Production and
immunological analysis of recombinant hepatitis B vaccine.
J Infect
13
Suppl A: 3-9.
29. Howard CR, Young PR, Lee S,
et al
. (1986) Hepatitis B surface anti-
gen polypeptide micelles from antigen expressed in Saccharomyces
cerevisiae.
J Virol Methods
14
(1): 25-35.
30. Keating GM, Noble S. (2003) Recombinant hepatitis B vaccine
(Engerix-B): a review of its immunogenicity and protective efficacy
against hepatitis B.
Drugs
63
(10): 1021-1051.
31. McAleer WJ, Buynak EB, Maigetter RZ,
et al
. (1984) Human hepati-
tis B vaccine from recombinant yeast.
Nature
307
(5947): 178-180.
32. Valenzuela P, Medina A, Rutter WJ,
et al
. (1982) Synthesis and assem-
bly of hepatitis B virus surface antigen particles in yeast.
Nature
298
(5872): 347-350.
33. Waters JA, Bailey C, Love C, Thomas HC. (1998) A study of the anti-
genicity and immunogenicity of a new hepatitis B vaccine using a panel
of monoclonal antibodies.
J Med Virol
54
(1): 1-6.
34. Beyene A, Basu A, Meyer K, Ray R. (2002) Hepatitis C virus envelope
glycoproteins and potential for vaccine development.
Vox Sang
83
Suppl 1: 27-32.
35. Bhopale GM, Nanda RK. (2004) Prospects for hepatitis C vaccine.
Acta Virol
48
(4): 215-221.
36. Hurwitz JL, Slobod KS, Lockey TD,
et al
. (2005) Application of the
polyvalent approach to HIV-1 vaccine development.
Curr Drug
Targets Infect Disord
5
(2): 143-156.
37. Idemyor V. (2003) Human immunodeficiency virus: scientific chal-
lenges impeding candidate vaccines.
HIV Clin Trials
4
(6): 421-424.
38. Lechmann M, Liang TJ. (2000) Vaccine development for hepatitis C.
Semin Liver Dis
20
(2): 211-226.
39. Logvinoff C, Major ME, Oldach D,
et al
. (2004) Neutralizing anti-
body response during acute and chronic hepatitis C virus infection.
Proc Natl Acad Sci USA
101
(27): 10149-10154.
40. Nara PL, Lin G. (2005) HIV-1: the confounding variables of virus
neutralization.
Curr Drug Targets Infect Disord
5
(2): 157-170.
41. Barany G, Kneib-Cordonier N, Mullen DG. (1987) Solid-phase peptide
synthesis: a silver anniversary report.
Int J Pept Protein Res
30
(6): 705-739.
42. Lebl M, Hachmann J. (2005) High-throughput peptide synthesis.
Meth Mol Biol
298
: 167-194.
